The purpose of this three-day conference is to provide an educational forum to discuss issues and applications related to pharmaceutical analysis. The conference connects leaders together to share new scientific and regulatory developments in the areas related to or with direct application for pharmaceutical analysis, product development, product quality and the analytical method lifecycle applications.
The Land O’ Lakes Conference on Pharmaceutical Analysis is well-recognized as one of the premier teaching conferences for colleagues in the pharmaceutical industry. Attendees are primarily from the pharmaceutical industry (worldwide) but also include those affiliated with governmental agencies, as well as academia.
The objectives for this conference include:
- Discuss and evaluate the major challenges to pharmaceutical analysis in today’s environment;
- List primary differences in analysis of large molecules and material characterization;
- Describe key new technologies and approaches for increasing laboratory efficiency;
- Evaluate new technological approaches to solving analytical challenges;
- Discuss possible answers to some of the global regulatory challenges to pharmaceutical analysis.
ABBREVIATED RESULTS from 2018 AUGUST LOL Conf
The Planning Committee for the 59th Annual Land O’Lakes Conference on Pharmaceutical Analysis invites interested parties to submit research poster abstracts for the 2019 Conference Poster Session on Wednesday, August 14, at the Fluno Center, Madison, Wisconsin.
All abstracts must be submitted via email to the University of Wisconsin by Monday, June 17, 2019. Proposals will be reviewed and evaluated by a review panel of Planning Committee members. Acknowledgement of receipt will be sent by e-mail, as well as notification of the acceptance or rejection of abstracts to primary presenters by July 10. Please do not call the University of Wisconsin to find out the status of your abstract(s).
To submit a poster for consideration, at least one author must be registered for the conference. If the poster is not accepted, authors have the right to cancel their registration by the early registration deadline of July 29 and will receive a full refund. Any author present at the Conference must be registered for the entire Conference.
Accepted abstracts will be placed on the University of Wisconsin Web site by July 14, 2019.
Call for Posters 2019 August Conference
Previous Poster Abstracts 2018
Joseph A. Albanese, PhD, Director – Analytical Strategy and Compliance, Discovery, Product Development and Supply, Janssen Research and Development, LLC, Spring House, PA
Ivelisse Colón-Rivera, PhD, Senior Director, Technical Operations, Vertex Pharmaceuticals, Boston, MA
Divyakant Desai, PhD, Research Fellow, Drug Product Science and Technology, Bristol-Myers Squibb, New Brunswick, NJ
Zongming Gao, PhD, Research Chemist, CDER/OPQ/OTR/Division of Pharmaceutical Analysis, Food and Drug Administration, St Louis, MO
Shaoqin Sarah Gong, PhD, Vilas Distinguished Achievement Professor, Department of Biomedical Engineering, University of Wisconsin, Madison, WI
Timothy Graul, PhD, Associate Research Fellow, Analytical Research & Development, Pfizer, Groton, CT
Russell L. Hertzler, PhD, Principal Research Scientist, Global Analytical R&D, AbbVie Inc., North Chicago, IL
Shelly Li, PhD, Senior Principal Scientist, Analytical Research and Development, Pharmaceutical Sciences Small Molecules, Pfizer Worldwide Research and Development, Groton, CT
David Q. Liu, PhD, Director, Analytical Development, Celgene, Summit, NJ
Joseph Medendorp, PhD, Director, Technical Operations, Vertex Pharmaceuticals Inc., Boston, MA
Kristy Moeller, Associate Research Scientist, Physical and Chemical Characterization, PPD, Middleton, WI
Shrinivas (Cheenu) Murti, PhD, MBA, Director, Global Regulatory Affairs CMC, Merck & Co., Inc., Rahway, NJ
Elizabeth Pierson, PhD, Associate Principal Scientist, Analytical Sciences, Merck Research Laboratories, Rahway, NJ
Asha Rajapakshe, PhD, Director, Analytical Commercialization Technology, Merck & Co., Inc., West Point, PA
George Reid, PhD, Principal Scientist – CMC, Cardinal Health Regulatory Science, Overland Park, KS
Kevin Roberson, Senior Director, Quality Assurance, Eurofins BioPharma Product Testing, Columbia MO
James M. Roberts, PhD, Scientific Director, Analytical Sciences & Development, R&D Medicinal Science & Technology, GlaxoSmithKline, Collegeville, PA
Jason Rodriguez, PhD, Laboratory Chief, Branch I, FDA Division of Pharmaceutical Analysis, St. Louis, MO
Carolyn Rosewall, PhD, Associate Research Scientist, PPD, Middleton, WI
Madhavi Srikoti, MS, Research Scientist, Drug Product Science and Technology, Bristol-Myers Squibb, New Brunswick, NJ
Derek Vrieze, MS, Associate Director Global Regulatory Affairs CMC, Vertex Pharmaceuticals, Inc., Boston, MA
Nathan Whitford, MBA, Site Director, Eurofins Lancaster Laboratories, Inc., Portage, MI
Asha Rajapakshe, PhD, Director, Analytical Commercialization TechnologyMerck & Co., Inc., West Point, PA, Conference Chair
Ivelisse Colón, PhD, Vertex Pharmaceuticals, Boston, MA, Past Conference Chair
Nathan Whitford, MBA, Eurofins Lancaster Laboratories, Inc., Portage, MI, 2020 Chair
Erik C. Burns, EdD, American Association of Pharmaceutical Scientists, Arlington, VA
James E. De Muth, PhD, University of Wisconsin, Madison, WI
Timothy Graul, PhD, Pfizer, Groton, CT
Russell L. Hertzler, PhD, AbbVie Inc., North Chicago, IL
Susan Lerke, PhD, Johnson & Johnson, Malvern, PA
Michael H. Murphy, Mallinckrodt Pharmaceuticals Company, St. Louis, MO
Horacio Pappa, PhD, United States Pharmacopeia Convention, Rockville, MD
George Reid, PhD, Cardinal Health Regulatory Sciences, Overland Park, KS
Stefanie Rentfrow, Perrigo, Allegan, MI
Jason Rodriguez, PhD, Food & Drug Administration, St. Louis, MO
Madhavi Srikoti, MS, Bristol-Myers Squibb. Princeton, NJ
Harley Wilcox, EAG Laboratories, Columbia, MO
Derek Wood, PPD, Middleton, WI
Naijun Wu, PhD, Celgene Corporation, Summit, NJ